Exosomal profiling should be used to monitor disease activity in MS patients: Yes

Abstract

Keywords

Biomarkers genetics immunology multiple sclerosis

Get full access to this article

View all access options for this article.

References

Charabati

Wheeler

Weiner

, et al. Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting. Cell 2023; 186: 1309–1327.

Abdelhak

Foschi

Abu-Rumeileh

, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol 2022; 18(3): 158–172.

Greene

Schmidt

Wilson

, et al. Cerebrospinal fluid myelin basic protein is frequently ordered but has little value: A test utilization study. Am J Clin Pathol 2012; 138(2): 262–272.

Kalluri

McAndrews

. The role of extracellular vesicles in cancer. Cell 2023; 186: 1610–1626.

Soleymani

Chen

Gonzalez-Kozlova

, et al. The human neurosecretome: Extracellular vesicles and particles (EVPs) of the brain for intercellular communication, therapy, and liquid-biopsy applications. Front Mol Biosci 2023; 10: 1156821.

Selmaj

Cichalewska

Namiecinska

, et al. Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Ann Neurol 2017; 81(5): 703–717.

Gill

Schorr

Gadani

, et al. Emerging imaging and liquid biomarkers in multiple sclerosis. Eur J Immunol 2023; 53(8): e2250228.

Surappa

Multani

Parlatan

, et al. Integrated “lab-on-a-chip” microfluidic systems for isolation, enrichment, and analysis of cancer biomarkers. Lab Chip 2023; 23: 2942–2958.

Galazka

Mycko

Selmaj

, et al. Multiple sclerosis: Serum-derived exosomes express myelin proteins. Mult Scler 2018; 24(4): 449–458.

10.

Agliardi

Guerini

Zanzottera

, et al. Myelin basic protein in oligodendrocyte-derived extracellular vesicles as a diagnostic and prognostic biomarker in multiple sclerosis: A pilot study. Int J Mol Sci 2023; 24: 894.